Fatty acid composition of the major phospholipids of Pneumocystic carinii: comparison with those in the lungs of normal and methylprednisolone-immunosuppressed rats
- PMID: 8606108
- PMCID: PMC173933
- DOI: 10.1128/iai.64.4.1407-1412.1996
Fatty acid composition of the major phospholipids of Pneumocystic carinii: comparison with those in the lungs of normal and methylprednisolone-immunosuppressed rats
Abstract
Large numbers of viable organisms can be isolated from the corticosteroid-immunosuppressed rat model of Pneumocystis carinii pneumonia. With the development of purification protocols that provide organism preparations of high purity, meaningful lipid biochemical analyses of this important opportunistic pathogen can now be conducted. The phospholipid class composition of the pathogen was reported earlier, together with observations of changes that occur in the rat lungs in response to methylprednisolone immunosuppression treatment. In this report, analyses of the effects of corticosteroids on the fatty acid compositions of the major lung phospholipids, individually isolated and purified by thin-layer chromatography, were elucidated and quantified by gas-liquid chromatography. In response to methylprednisolone, there was a relative increase in palmitate and there were decreases in several unsaturated fatty acids of the rat whole-lung total polar lipids leading to a doubling of the saturation index. Reciprocal changes in the relative concentrations of palmitate and stearate in phosphatidylethanolamine, phosphatidylinositol, lysophosphatidylcholine, and cardiolipin were observed, suggesting that there is tight control of acylation of these phospholipids in the lung. Detailed phospholipid fatty acid analyses were also performed with mixed life cycle stages of P. carinii organisms. The most abundant phospholipids, phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol, had much higher concentrations of oleic acid and lower concentrations of palmitate in P. carinii than in lung tissue. Sphingomyelin in lung tissue and P. carinii differed from the glycerophospholipids by the presence of high levels of saturated C(22) and C(24) fatty acids. This study represents the most comprehensive fatty acid analysis of rat lung phospholipids and the changes that occur in response to corticosteroid treatment. It is the first report about the fatty acids of individual phospholipids of the opportunistic protist P. carinii carinii.
Similar articles
-
Characterizations of neutral lipid fatty acids and cis-9,10-epoxy octadecanoic acid in Pneumocystis carinii carinii.Infect Immun. 1996 Oct;64(10):4105-14. doi: 10.1128/iai.64.10.4105-4114.1996. Infect Immun. 1996. PMID: 8926076 Free PMC article.
-
The lipids of Pneumocystis carinii.Clin Microbiol Rev. 1998 Jan;11(1):27-41. doi: 10.1128/CMR.11.1.27. Clin Microbiol Rev. 1998. PMID: 9457427 Free PMC article. Review.
-
Phospholipid composition of Pneumocystis carinii carinii and effects of methylprednisolone immunosuppression on rat lung lipids.Infect Immun. 1995 Apr;63(4):1286-90. doi: 10.1128/iai.63.4.1286-1290.1995. Infect Immun. 1995. PMID: 7890386 Free PMC article.
-
Characterizations of Pneumocystis carinii and rat lung lipids: glyceryl ethers and fatty alcohols.J Lipid Res. 1998 Oct;39(10):1907-17. J Lipid Res. 1998. PMID: 9788237
-
Detailed analyses of individual neutral lipid classes of Pneumocystis.J Eukaryot Microbiol. 1996 Sep-Oct;43(5):51S. doi: 10.1111/j.1550-7408.1996.tb04986.x. J Eukaryot Microbiol. 1996. PMID: 8822853
Cited by
-
Characterizations of neutral lipid fatty acids and cis-9,10-epoxy octadecanoic acid in Pneumocystis carinii carinii.Infect Immun. 1996 Oct;64(10):4105-14. doi: 10.1128/iai.64.10.4105-4114.1996. Infect Immun. 1996. PMID: 8926076 Free PMC article.
-
Sterol structure and sphingomyelin acyl chain length modulate lateral packing elasticity and detergent solubility in model membranes.Biophys J. 2003 Dec;85(6):3788-801. doi: 10.1016/S0006-3495(03)74794-8. Biophys J. 2003. PMID: 14645069 Free PMC article.
-
C27 to C32 sterols found in Pneumocystis, an opportunistic pathogen of immunocompromised mammals.Lipids. 2000 Mar;35(3):317-24. doi: 10.1007/s11745-000-0528-8. Lipids. 2000. PMID: 10783009
-
The lipids of Pneumocystis carinii.Clin Microbiol Rev. 1998 Jan;11(1):27-41. doi: 10.1128/CMR.11.1.27. Clin Microbiol Rev. 1998. PMID: 9457427 Free PMC article. Review.
-
Pneumocystis carinii pneumonia in scid mice induced by viable organisms propagated in vitro.Infect Immun. 1996 Nov;64(11):4643-7. doi: 10.1128/iai.64.11.4643-4647.1996. Infect Immun. 1996. PMID: 8890219 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources